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DNA methylation has the potential to be a clinically 
important biomarker in cancer. This communication reports 
a real-time and label-free biosensing strategy for DNA 
methylation detection in cancer cell line. This has been 
achieved by using surface plasmon resonance biosensing 
combined with the highly specific molecular inversion probe 
based amplification method, which requires only 50 ng of 
bisufite treated genomic DNA. 
DNA methylation is the process in which a methyl group is added to 
the carbon-5 position of cytosine in a CpG dinucleotide1. Differences 
in DNA methylation levels between normal and cancer cells have 
been proposed as biomarkers to retrieve clinically relevant information 
regarding the stage of disease or cancer subtype, which in turn might 
help to underpin prognosis and appropriate mode of treatment.2 Much 
attention has been focused on the detection of DNA methylation using 
different sensors schemes,3-9 however the most widely used 
techniques for DNA methylation are bisulfite sequencing10 and affinity-
enrichement.5 Bisulfite-sequencing is a very sensitive technique 
capable of retrieving single cytosine methylation information, but the 
methodology itself is complex and prone to DNA amplification errors. 
Detecting a series of several CpG sites in a region (e.g., the promoter 
region) has the potential to extract the desired methylation information 
without requiring single CpG site resolution. In this context, affinity 
based methods using methyl binding domain proteins that specifically 
recognize methylated-CpG rich regions offer a better alternative. 
While all these methods have excellent analytical performances in 
detecting regional DNA methylation, they are poorly suited for routine 
diagnostics due to the high running cost, long assay time, complicated 
chemistries and detection procedures.  
 Surface Plasmon resonance (SPR) is one of the most powerful 
alternative analytical methods for circumventing these type of 
problems,  
 
while providing label-free, real-time, reproducible and sensitive 
biomolecular detection.11 In SPR biosensing, the binding of the target 
analyte to its surface-bound receptor counterpart produces a local 
change in refractive index over time at the sensing surface, which is 
quantitative with the relative mass increase associated with target 
capture, thus enabling the real-time and label-free readout of these 
targets12. This method has previously been used to detect regional 
DNA methylation using proteins with affinity to CpG rich regions.6,9 
However, the reproducibility of affinity based methods depends on 
antibody specificity and CG-density.13  
  
Herein, we report a novel strategy which synergistically couples the 
label-free, real-time nature of the SPR biosensor with the sensitive, 
specific and multiplexing capability of the molecular inversion probes 
(MIPs) for accurate detection of regional DNA methylation. The 
principle involves utilizing a MIP, which is a single stranded 
oligonucleotide (ss-oligo) capable of hybridizing to a genomic DNA 
target by two inverted recognition ends.14,15 MIPs are well-known for 
their capability for deciphering genetic16 and epigenetic17,18 information 
from multiple regions across the genome in a highly specific and 
sensitive way. A MIP binding to the single stranded-DNA generates a 
gap of length one or several bases between the hybridized recognition 
ends. Following the gap-filling and enzymatic ligation, a circularized 
DNA probe carrying the imprinted information from the interrogated 
region is generated (for details, see Fig S1, ESI†). PCR amplification 
of the circularized MIPs employing universal primers enables 
detection of the amplified-amplicons using DNA array platform15 or 
beads.18 The superior specificity and accuracy of MIP based 
approches over conventional primer binding approaches can be 
attributed to the enzymatic digestion of all non-circularized probes and 
use of the universal primers for ampliflying  all MIPs. This, in 
combination with SPR has the potential to sensitively and specifically 
measure regional DNA methylation in real-time and label-free manner, 
while avoiding the use of affinity based proteins. 
 Scheme 1 outlines a strategy to combine MIPs and SPR for 
regional methylation detection of a cluster of eight CpG sites located 
within a span of 53 bases downstream of the transcription start site of 
the engrailed (En1) gene (Fig. S1 and S2, ESI†). The methylation 
status of this region has been recently highlighted as a potential 
biomarker in several cancer types.19 According to our sequencing data 
(Fig. S2, ESI†), this region is also methylated in MCF7 breast cancer 
cells, thus we selected this cell type as a source for methylated DNA. 
For unmethylated DNA, we used whole genome amplified (WGA) 
DNA.20 
 
Scheme 1. Methodological approach for the label-free and real-time detection 
of regional DNA methylation based on MIP and SPR. Inset, typical SPR 
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sensograms for the reading oligo step hybridized with methylated and 
unmethylated targets. 
The assay consisted of three steps: (i) DNA extraction and bisulfite 
treatment to convert the epigenetic change into base changes, (ii) 
DNA investigation by MIPs followed by the generation of single 
stranded-DNA amplicons using asymmetric PCR and (iii) reading the 
methylation status of amplicons with SPR using a sandwich approach 
(see ESI† for details). 
 Briefly, after extraction from cell lines (Scheme 1, step 1), genomic 
DNA was bisulfite treated enabling the selective conversion of 
unmetylated cytosines into uracile while leaving methylated ones 
unchanged. Then, the region of interest was investigated with a MIP 
using a fill-in approach. In the fill-in approach, the MIP binds to the 
DNA, and generates a broad gap of several bases (i.e., 53 bases) 
between the MIP recognition ends, which represents the methylated 
region to be investigated. This gap was then filled by a polymerase 
and subsequently ligated by a ligase, leading to a circularized DNA 
probe carrying the imprinted information from the investigated region 
(step 2). In this way the whole region was uniquely studied by a single 
MIP, which contained the methylation information from the region of 
interest. Finally, the MIP circularized product was amplified by 
asymmetric PCR to generate a single stranded-amplicon which was 
captured by a receptor oligo sequence previously immobilized onto 
the SPR sensing surface (step 3). For investigating the methylation 
information carried by the captured PCR amplicons, a synthetic 
reading ss-oligo was specifically hybridized to the region of interest 
contained in the MIP amplicon sequence. Since this reading oligo was 
designed to specifically match the methylated epigenotype, 
hybridization could only take place on PCR amplicons generated from 
methylated DNA templates. When monitoring the SPR signal 
generated with the successful hybridization of reading oligo, there was 
a clear correlation between the presence of the methylated amplicon 
and increase of the SPR signal (inset in Scheme 1). The presence of 
methylated amplicon increases the mass on the SPR sensing layer 
thereby increasing SPR signal.  
 Prior to detecting cytosine methylation in DNA derived from MCF7 
cell line and WGA, we tested the applicability of this sensing scheme 
with short synthetic DNA sequences mimicking the methylated (S-
MIPMeth) and unmethylated (S-MIPUnmeth) epigenotypes (Table S1, 
ESI†). Standard gold-thiol chemistry was used to immobilize 1 µM 
thiolated capture probe in the presence of 100 nM mercaptohexanol 
(MCH) onto the SPR sensing surface (Figure 1, condition I). MCH was 
employed as backfiller to prevent non-specific adsorption on gold 
surface and to increase hybridization efficiency.21 Since both 
methylated and unmethylated targets had the same receptor matching 
sequence, they should be equivalently captured on the sensor 
surface. However, unmethylated targets generated relatively larger 
signals compared to that of the methylated one. A possible 
explanation for this enhanced response would be the larger 
nonspecific adsorption of adenine-enriched unmethylated target onto 
the gold surface (adenine bases are reported to have a large affinity 
towards gold22). We also believe that the presence of secondary 
structures (hairpins) in the targets could have a contribution towards 
this nonspecific adsorption, since the receptor-matching region would 
be less available for hybridization. The larger signal for 300 nM 
reading oligo hybridized with 200 nM unmethylated target (Condition I, 
Bar in aquamarine) further highlighted that a significant bias towards 
the unmethylated target during the reading oligo step might be 
introduced. In order to avoid these problems, we used (i) a monolayer 
with the high MCH loading as backfiller, and (ii) helper 
oligonucleotides,23 i.e. short ss-oligos partially matching with target 
sequences (Fig. S2, ESI† for details) to unfold its secondary structure.  
As can be seen in Fig 1 (Bars in Condition II), the combined action of 
extra MCH loading and addition of helpers to the targets increased the 
SPR signals for both the methylated and unmethylated targets 
compared to those obtained under Condition I. This is probably due to 
the more availability for receptor matching region for the hybridization 
with surface bound thiolated DNA. It is also noted that the signal for 
the reading oligo with unmethylated target was reduced significantly 
(i.e., almost similar to background level) while that for the methylated 
target increased slightly. This is probably due to the combined effect 
of helpers and MCH backfilling where MCH reduced non-specific 
adsorption on gold surface and helper oligos increased the specificity 
of the hybridization.  
Fig. 1. SPR responses for the capture of 200 nM synthetic methylated (black) and 
200 nM unmethylated (red) targets followed by their detection with 300 nM 
synthetic reading oligo (blue for methylated targets; aquamarine for 
unmethylated targets). The self-assembled monolayer of the thiolated capture 
probe was formed via (Condition I) ex-situ immobilisation of 1 µM thiolated DNA 
+ 100 nM aqueous MCH and (Condition II) condition I + in-situ immobilisation of 
1 mM aqueous MCH solution + capture of synthetic targets pre-treated with 
helper oligos. Right Panel: SPR sensorgrams of the reading oligos hybridized with 
methylated (blue) and unmethylated (aquamarine) targets. Each data point in 
left Panel represents the average of three separate trials (n =3), and error bars 
represent standard deviation of measurements within each experiments. 
Relative standard deviation was found to be <7.0% (n = 3).  
 To evaluate the detection limit of our approach, we measured 
SPR signal for the capture of 100 to 400 nM of the synthetic 
methylated targets (black Bars in Fig. 2A). Each concentration 
measurement was followed by a 300-500 nM reading oligo 
measurement step (blue bars in Fig 2A). Clearly, the SPR signal was 
a function of concentration of synthetic methylated targets. The 
minimum detectable concentration for methylated target was 100 nM. 
It is noted that the SPR signal for the reading oligo was also increased 
with increasing the concentration of methylated targets. This is 
because larger number of methylated sequences captured (as a 
function of concentration of target) onto sensing surface could 
hybridised with higher amount of reading oligo, and hence enhanced 
SPR signal was observed. 
 The specificity of our assay was tested against regional 
methylated target in the presence of an excess of unmethylated target 
(Fig. 2B). Clearly, 100 nM methylated targets can easily be detected 
in the presence of 300 nM of unmethylated target (this sample mixture 
corresponds to 25% methylation). This level of specificity indicates 
that our method could be applicable for epigenetic studies on 
biological samples such as samples containing a heterogeneous 
mixture of tumor and adjacent normal cells. Additionally, since the 
response from the 25% methylated target was significantly higher than 
that of 0% methylation (Fig. 2B), we estimated that our approach was 
sensitive at least for 25% methylation changes. 
 We next demonstrated the applicability of our methodology for the 
reading of DNA methylation in a biological extract by performing the 
   
assay on breast cancer MCF7 cell line DNA. To avoid any potential 
bias towards a particular epigenotype, the target EN1 copy number in 
DNA from MCF7 and WGA DNA were normalized prior to MIP assay. 
This assay required only 50 ng of bisulfite treated DNA and 1 pg (22 
attomoles) of MIPs which generated 60 µL of MIP derived ss-
amplicons. We found that 30 µL of these amplicons spiked in 200 µL 
of buffer solution containing the oligonucleotide helpers were sufficient 
to obtain a significant detectable signal with the reading oligo (Fig. 
2C). The average reading signal for the amplicons from MCF7 cells 
was about 15-times larger than that of those from WGA DNA, 
indicating that the target region in MCF7 cells were methylated. The 
sensitivity and specificity of signals obtained for the reading of 30 µL 
of MIP amplicon was comparable to that obtained for 200 nM 
synthetic targets.  
 
 Finally, reusability of the receptor monolayer was examined by 
comparing SPR signals generated for 200 nM synthetic methylated 
target over seventy (n = 70) independent measurements on the same 
monolayer surface. The monolayer was regenerated by using 50% 
formamide aqueous solution in-between two successive 
measurements. Fig. 2D shows that monolayer can be regenerated 
without losing any capture performance over this long period of SPR 
measurements. This feature of our approach could be very useful for 
diagnostic applications where routine monitoring of different patient’s 
samples could be addressed using the same sensor chip, allowing it 
to be a simpler, faster, robust and inexpensive alternative to traditional 
detection methodologies. 
 In summary, we have demonstrated a rapid, label-free and real-
time detection of regional DNA methylation. The combined use of MIP 
and SPR detection facilitates three critical improvements to the 
traditional DNA methylation detection methods that include: (i) real-
time and label-free detection giving instant read-outs by avoiding 
artifacts generally associated with the use of labels, (ii) cost-effective 
approach requiring minimal operational requirements (e.g., syringe 
pump and custom made SPR set-up), and (iii) potential multiplexing 
capability of MIPs and an multi-channeled SPR platform which can 
facilitate high throughput analysis. Although further validation needs to 
be done to examine variation in methylation in clinically relevant 
samples, we believe that these unique features along with the high 
specificity, sensitivity, and ability to detect a low percentage of 
methylation in presence of large excess of unmethylated DNA, will 
make this strategy very appealing for diagnostic purposes. 
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Fig. 2. (A) SPR sensorgram for 100 nM synthetic methylated target (S-
MIPMeth) capture followed by 300 nM reading oligo step onto the sensor 
surface.   Dependence of the SPR signals on the concentration of S-MIPMeth 
is showed in the right panel. (B) SPR sensorgrams obtained at 100, 75, 50, 
25 and 0% methylation. The samples were made via mixing 400, 300, 200, 
100 and 0 nM S-MIPMeth target with 0, 100, 200, 300 and 400 nM synthetic 
unmethylated target (S-MIPUnmeth), respectively. (C) SPR sensorgram for 
capturing and reading of the EN1 region from (i) 30 µL MCF7 derived (i.e., 
methylated, black) and WGA derived (i.e., unmethylated, red) MIPs 
amplicons, and (D) 1st (black) and 70th (orange) measurements for 200 nM 
synthetic methylated target. 
